Biotechnology & Drugs news, Biotechnology & Drugs industry, industry News

▮ More

5 Top Losers In Healthcare Sector (NSPR, NTEC, ACRS…)

6 Top Gainers In Healthcare Sector (AIM, EDSA, ARAV…)

Mobile Games Can Help Detect Cognitive Deterioration : Study

Wave Life Raring To Go The Distance

5 Top Losers In Healthcare Sector (ZYNE, PTCT, MRNS…)

5 Top Gainers In Healthcare Sector (LXRX, ECOR, ARAV…)

FDA, Canada, Australia Collaborate On Cancer Drugs Review

Novartis : Type 2 Diabetes Study Shows Long-term Clinical Benefits

FDA Makes 1st Approval Under Project Orbis, KDMN On Watch, TBIO Down After-hrs

AstraZeneca Gets Full Responsibility For Commercialising Linzess In China

AstraZeneca Amends Collaboration With Ironwood For Linzess In China

Roche :FDA Grants Breakthrough Therapy Designation For Gazyva In Lupus Nephritis

Roche Says FDA Granted Breakthrough Therapy Designation To Gazyva

FDA Grants Breakthrough Therapy Designation For Genentech's Gazyva

5 Top Losers In Healthcare Sector (ONTX, LPTX, SLRX…)

6 Top Gainers In Healthcare Sector (ACRS, NSPR, AVDL…)

Sienna Biopharma To File For Bankruptcy

Philips Launches Sleep Position Therapy Device - Quick Facts

Study To Examine Link Between Copper And Alzheimer's

Merck: FDA Grants Priority Review For Investigational Ebola Vaccine

Hikma Pharma Launches New Prefilled Syringes In US

XLRN Pulls The Plug On FSHD Study, KPTI Well Funded, ACRS Up On Wart Trial Data

Acceleron Pharma's ACE-083 Fails In Phase 2 Study For FSHD

AVITA Gets FDA IDE Approval Of Soft Tissue Reconstruction Pivotal Clinical Trial

Novartis: Cosentyx Phase III Trial Meets Primary Endpoint At Week 16

Industries >>

Biotechnology & Drugs News

AstraZeneca Amends Collaboration With Ironwood For Linzess In China

Roche Says FDA Granted Breakthrough Therapy Designation To Gazyva

FDA Grants Breakthrough Therapy Designation For Genentech's Gazyva